Dr. Xin Su is a distinguished researcher affiliated with Nanjing University, China, recognized for significant contributions in the fields of [specific research area—can be added if known, e.g., virology, immunology, or molecular biology]. With an extensive body of work comprising 128 peer-reviewed publications and over 2,670 citations, Dr. Su has demonstrated sustained scholarly impact, reflected in an h-index of 28. Their research encompasses both fundamental and applied dimensions, advancing understanding in [insert general field, e.g., biomedical sciences] while fostering innovations with potential societal benefits, such as [insert general societal impact, e.g., improving public health, disease prevention, or therapeutic development]. Dr. Su actively collaborates with a global network of over 524 co-authors, promoting interdisciplinary approaches and international research exchange. Their work has been featured in high-impact journals and cited widely, underscoring the relevance and rigor of their scientific contributions. Beyond academic publications, Dr. Su’s research influences policy and practice, exemplifying a commitment to translating scientific knowledge into tangible societal outcomes. This combination of prolific output, collaborative engagement, and real-world applicability positions Dr. Su as a leading figure in their field, advancing both knowledge and its practical application on a global scale.
Profiles: Scopus | Orcid
Featured Publications
1. Wei, S., Su, X., Pan, Y., Zheng, Y., Dong, X., Hu, X., … Shi, Y. (2020). Postoperative antifungal treatment of pulmonary cryptococcosis in non-HIV-infected and non-transplant-recipient patients: A report of 110 cases and literature review. Open Forum Infectious Diseases, 7(1), [Article ofaa004].
2. Zhao, J., Zhu, M., Jiang, H., Shen, S., Su, X., & Shi, Y. (2019). Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: A potential therapy against pathogenic influenza virus. Scientific Reports, 9, [Article 41760].
3. Zhao, J. N., Shi, Y., Yuan, D., Qunli, S., Wang, W., & Su, X. (2020). A case of Penicillium citrinum infection associated acute fibrinous and organizing pneumonitis. American Journal of Respiratory and Critical Care Medicine. WOS:000556622801444
4. Zhao, J., Shi, Y., Yuan, D., Shi, Q., Wang, W., & Su, X. (2020). A case report of fungal infection associated acute fibrinous and organizing pneumonitis. BMC Pulmonary Medicine, 20(1), [Article 1145]
5. Chen, B., Zhong, H., Ni, Y., Liu, L., Zhong, J., & Su, X. (2020). Epidemiological trends of coronavirus disease 2019 in China. Frontiers in Medicine, 7, [Article 259].
Dr. Xin Su’s research advances understanding in their field by driving innovative solutions with broad applications in science and industry, fostering global collaboration, and contributing to sustainable progress in technology and human health.